Gregory Engel
Directeur/Membre du Conseil chez Canadian Chamber of Commerce
Postes actifs de Gregory Engel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Canadian Chamber of Commerce
Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada. | Directeur/Membre du Conseil | 30/10/2020 | - |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gregory Engel
Anciens postes connus de Gregory Engel
Sociétés | Poste | Début | Fin |
---|---|---|---|
ORGANIGRAM HOLDINGS INC. | Directeur/Membre du Conseil | 13/03/2017 | 03/05/2021 |
Directeur Général | 13/03/2017 | 03/05/2021 | |
Tilray Canada Ltd.
Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada. | Directeur Général | 01/01/2015 | 01/06/2016 |
Forest Laboratories Canada, Inc.
Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada. | Corporate Officer/Principal | 01/11/2010 | 01/08/2014 |
Formation de Gregory Engel
University of Guelph | Undergraduate Degree |
Statistiques
Internationale
Canada | 7 |
Opérationnelle
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Process Industries | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORGANIGRAM HOLDINGS INC. | Process Industries |
Entreprise privées | 4 |
---|---|
Tilray Canada Ltd.
Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada. | Health Technology |
Canadian Chamber of Commerce
Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada. | Commercial Services |
Forest Laboratories Canada, Inc.
Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada. | Health Technology |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Health Technology |
- Bourse
- Insiders
- Gregory Engel
- Expérience